Catherine Mair

449 total citations
7 papers, 130 citations indexed

About

Catherine Mair is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Catherine Mair has authored 7 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 2 papers in Molecular Biology and 1 paper in Infectious Diseases. Recurrent topics in Catherine Mair's work include Herpesvirus Infections and Treatments (2 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). Catherine Mair is often cited by papers focused on Herpesvirus Infections and Treatments (2 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). Catherine Mair collaborates with scholars based in United Kingdom, Italy and Germany. Catherine Mair's co-authors include Katie Ewer, Adrian V. S. Hill, Grazia Camarda, Nicholas Davis‐Poynter, Gaia Spinetti, Maurizio C. Capogrossi, Monica Napolitano, Giovanni Bernardini, Sarah C. Gilbert and Alison M. Lawrie and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and Journal of Leukocyte Biology.

In The Last Decade

Catherine Mair

7 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Mair United Kingdom 6 68 51 46 23 17 7 130
Jane Fontenot United States 8 41 0.6× 36 0.7× 73 1.6× 14 0.6× 6 0.4× 13 161
Duncan Bellamy United Kingdom 8 62 0.9× 34 0.7× 59 1.3× 8 0.3× 30 1.8× 15 124
Juliana C. Small United States 6 40 0.6× 35 0.7× 47 1.0× 21 0.9× 51 3.0× 12 137
Ilhan Tomris Netherlands 9 76 1.1× 46 0.9× 49 1.1× 13 0.6× 14 0.8× 13 171
Elizabeth M. Parzych United States 8 81 1.2× 89 1.7× 31 0.7× 29 1.3× 34 2.0× 13 181
Ron Chow Canada 4 112 1.6× 30 0.6× 21 0.5× 16 0.7× 10 0.6× 6 137
Chieh-Yu Liang United States 8 48 0.7× 77 1.5× 83 1.8× 8 0.3× 13 0.8× 12 200
Gurpreet Brar United States 4 54 0.8× 36 0.7× 33 0.7× 8 0.3× 12 0.7× 5 102
Lara M. Jeworowski Germany 7 26 0.4× 47 0.9× 96 2.1× 34 1.5× 43 2.5× 11 163
Raquel A. Binder United States 7 31 0.5× 16 0.3× 132 2.9× 32 1.4× 16 0.9× 13 199

Countries citing papers authored by Catherine Mair

Since Specialization
Citations

This map shows the geographic impact of Catherine Mair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Mair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Mair more than expected).

Fields of papers citing papers by Catherine Mair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Mair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Mair. The network helps show where Catherine Mair may publish in the future.

Co-authorship network of co-authors of Catherine Mair

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Mair. A scholar is included among the top collaborators of Catherine Mair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Mair. Catherine Mair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Butler, Christopher, Pedro M. Folegatti, Julie Allen, et al.. (2021). Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS). Vaccines. 9(8). 851–851. 10 indexed citations
2.
Bowyer, Georgina, Hannah Sharpe, Navin Venkatraman, et al.. (2020). Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells. The Journal of Experimental Medicine. 217(7). 30 indexed citations
3.
Folegatti, Pedro M., Duncan Bellamy, Rachel Roberts, et al.. (2019). Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine. Vaccines. 7(2). 40–40. 19 indexed citations
4.
Folegatti, Pedro M., Duncan Bellamy, Amy Flaxman, et al.. (2019). Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line. Vaccines. 7(1). 33–33. 21 indexed citations
5.
Ewer, Katie, Christopher M. Smith, Georgina Bowyer, et al.. (2018). DURABILITY OF IMMUNE RESPONSES INDUCED BY THREE LEADING CANDIDATE EBOLA VACCINE REGIMES; RVSV ZEBOV, CHAD3 EBO Z-MVA BN-FILO AND ADHU26. ZEBOV-MVA BN FILO. American Journal of Tropical Medicine and Hygiene. 99. 214–215. 1 indexed citations
6.
Duncan, Imogen, et al.. (2002). In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions. Journal of Leukocyte Biology. 72(3). 522–529. 21 indexed citations
7.
Camarda, Grazia, Gaia Spinetti, Giovanni Bernardini, et al.. (1999). The Equine Herpesvirus 2 E1 Open Reading Frame Encodes a Functional Chemokine Receptor. Journal of Virology. 73(12). 9843–9848. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026